See more : Squarespace, Inc. (SQSP) Income Statement Analysis – Financial Results
Complete financial analysis of Profarma Distribuidora de Produtos Farmacêuticos S.A. (PFRM3.SA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Profarma Distribuidora de Produtos Farmacêuticos S.A., a leading company in the Medical – Distribution industry within the Healthcare sector.
- T&D Holdings, Inc. (TDHOF) Income Statement Analysis – Financial Results
- Usinas Siderúrgicas de Minas Gerais S.A. (USIM3.SA) Income Statement Analysis – Financial Results
- Exponent, Inc. (EXPO) Income Statement Analysis – Financial Results
- Tamai Steamship Co., Ltd. (9127.T) Income Statement Analysis – Financial Results
- Xinjiang Winka Times Department Store Co.,Ltd. (603101.SS) Income Statement Analysis – Financial Results
Profarma Distribuidora de Produtos Farmacêuticos S.A. (PFRM3.SA)
About Profarma Distribuidora de Produtos Farmacêuticos S.A.
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company operates through Distribution, and Retail segments. It provides branded medicines, generic drugs, and over-the-counter (OTC) medicines; personal hygiene, beauty, and cosmetic products, such as shampoos, conditioners, treatment creams and hair dyes, diapers and children's products, soaps , deodorants, oral care products, sunscreens, male products, cosmetics, makeup and skin products, and others; and hospital products, including injectable and infusion drugs for oncology, endocrinology, rheumatology, infectology, hematology, and other specialties. The company also offers vaccines for influenza, HPV, meningitis, hepatitis, chickenpox, dengue, and other diseases; special medicines intended for the treatment of rare and complex diseases; exclusive hygiene and beauty products, vitamins, and workshops products under the Nº21, GOnutri, and Bem Básico brands; and convenience products, including food products, pressure gauges, scales, and related products. In addition, it provides complementary services, such as promotional and logistical support, implementation of promotional campaigns, product recall, development of customized projects to offer laboratories solutions, and management of clinical procedures. As of December 31, 2019, the company operated eleven distribution centers located in the states of Alagoas, Bahia, Espírito Santo, Goiás, Minas Gerais, Paraíba, Paraná, Pernambuco, Rio Grande do Sul, Rio de Janeiro, and São Paulo, as well as approximately 196 stores in the states of Rio de Janeiro, Goiás, Tocantins, Mato Grosso, and Distrito Federal under the Drogarias Tamoio, Drogasmil, Farmalife, and Rede Rosário brands. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.66B | 7.82B | 6.41B | 5.48B | 4.80B | 4.27B | 4.10B | 4.08B | 3.47B | 3.45B | 3.47B | 3.38B | 3.32B | 2.63B | 2.58B | 2.54B | 2.27B | 1.73B | 1.52B |
| Cost of Revenue | 7.37B | 6.67B | 5.51B | 4.72B | 4.06B | 3.59B | 3.40B | 3.46B | 3.03B | 3.02B | 3.16B | 3.03B | 3.15B | 2.44B | 2.31B | 2.31B | 2.05B | 1.57B | 1.36B |
| Gross Profit | 1.29B | 1.15B | 907.57M | 763.57M | 737.84M | 680.91M | 700.97M | 625.25M | 436.97M | 431.97M | 307.48M | 355.32M | 163.68M | 181.14M | 263.60M | 220.69M | 216.98M | 159.31M | 156.27M |
| Gross Profit Ratio | 14.92% | 14.66% | 14.15% | 13.93% | 15.37% | 15.94% | 17.09% | 15.31% | 12.61% | 12.52% | 8.86% | 10.50% | 4.93% | 6.90% | 10.22% | 8.70% | 9.56% | 9.22% | 10.28% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 61.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 242.84M | 25.12M | 140.07M | 120.92M | 127.06M | 131.76M | 139.50M | 126.73M | 95.16M | 98.28M | 105.99M | 87.02M | 54.47M | 49.41M | 50.84M | 50.39M | 53.79M | 38.73M | 37.34M |
| Selling & Marketing | 803.52M | 86.89M | 351.59M | 294.20M | 293.43M | 347.25M | 381.33M | 255.17M | 262.42M | 265.46M | 227.24M | 169.61M | 149.99M | 152.64M | 143.04M | 72.17M | 65.73M | 41.10M | 34.00M |
| SG&A | 1.05B | 112.00M | 491.66M | 415.12M | 420.49M | 479.01M | 520.82M | 381.90M | 357.57M | 363.74M | 333.22M | 256.63M | 204.46M | 202.05M | 193.88M | 122.57M | 119.51M | 79.83M | 71.34M |
| Other Expenses | 0.00 | 790.56M | 291.18M | 231.91M | 258.99M | 22.51M | 56.25M | 38.72M | 27.93M | 50.96M | -97.90M | 14.30M | -107.06M | -89.54M | -28.90M | 17.85M | 10.48M | 26.71M | 36.76M |
| Operating Expenses | 1.05B | 902.56M | 782.84M | 647.03M | 679.48M | 628.09M | 709.10M | 543.52M | 385.50M | 414.70M | 235.33M | 270.93M | 97.40M | 112.51M | 164.98M | 140.42M | 129.99M | 106.54M | 108.10M |
| Cost & Expenses | 8.42B | 7.57B | 6.29B | 5.36B | 4.74B | 4.22B | 4.11B | 4.00B | 3.41B | 3.43B | 3.40B | 3.30B | 3.25B | 2.56B | 2.48B | 2.46B | 2.18B | 1.68B | 1.47B |
| Interest Income | 27.42M | 8.68M | 4.90M | 4.26M | 3.22M | 7.46M | 12.36M | 29.45M | 14.91M | 3.84M | 0.00 | 19.35M | 10.99M | 10.39M | 37.77M | 6.96M | 14.72M | 3.91M | 1.26M |
| Interest Expense | 168.31M | 149.20M | 76.16M | 67.22M | 93.13M | 66.65M | 133.28M | 158.03M | 64.19M | 82.60M | 0.00 | 0.00 | 42.18M | 39.00M | 37.77M | 0.00 | 28.28M | 33.49M | 30.10M |
| Depreciation & Amortization | 148.52M | 138.22M | 125.89M | 101.94M | 95.30M | 33.73M | 31.47M | 19.50M | 16.27M | 16.28M | 8.92M | 7.86M | 6.45M | 5.44M | 5.49M | 4.28M | 3.05M | 2.23M | 2.17M |
| EBITDA | 353.37M | 380.44M | 226.44M | 199.27M | 206.76M | 75.74M | 18.66M | 101.24M | 61.88M | 33.55M | 81.08M | 84.82M | 69.22M | 63.17M | 96.45M | 77.83M | 90.03M | 55.00M | 50.34M |
| EBITDA Ratio | 4.08% | 4.68% | 3.87% | 3.68% | 5.06% | 1.65% | 0.16% | 3.06% | 1.79% | 0.97% | 2.34% | 2.73% | 2.52% | 2.82% | 4.04% | 3.34% | 3.97% | 3.18% | 3.31% |
| Operating Income | 245.62M | 227.88M | 122.16M | 99.84M | 147.08M | -626.00M | -712.23M | -549.09M | -19.82M | -60.63M | 19.96M | 84.39M | 66.28M | 40.03M | 98.62M | 40.45M | 53.91M | 52.78M | 48.17M |
| Operating Income Ratio | 2.84% | 2.92% | 1.90% | 1.82% | 3.06% | -14.66% | -17.37% | -13.44% | -0.57% | -1.76% | 0.58% | 2.49% | 2.00% | 1.52% | 3.82% | 1.60% | 2.38% | 3.05% | 3.17% |
| Total Other Income/Expenses | -164.03M | -129.44M | -73.41M | -60.08M | -161.08M | -105.40M | -201.73M | -172.87M | -99.22M | -128.87M | -76.89M | -28.61M | -31.19M | -28.61M | -26.72M | -32.87M | 0.00 | -55.04M | -28.91M |
| Income Before Tax | 81.59M | 78.97M | 48.75M | 33.15M | 21.56M | -30.13M | -153.61M | -52.42M | -19.82M | -60.63M | 19.96M | 55.77M | 35.09M | 40.03M | 71.90M | 40.45M | 53.91M | -2.26M | 19.26M |
| Income Before Tax Ratio | 0.94% | 1.01% | 0.76% | 0.60% | 0.45% | -0.71% | -3.75% | -1.28% | -0.57% | -1.76% | 0.58% | 1.65% | 1.06% | 1.52% | 2.79% | 1.60% | 2.38% | -0.13% | 1.27% |
| Income Tax Expense | 3.74M | -6.07M | -30.37M | -28.65M | 9.58M | -20.40M | -40.89M | -3.46M | 1.36M | -8.25M | 896.00K | 13.49M | 5.43M | 5.64M | 19.10M | 48.88M | 39.95M | 1.29M | 2.98M |
| Net Income | 70.40M | 80.87M | 78.19M | 52.33M | 11.98M | -9.73M | -112.72M | -48.96M | -21.18M | -52.12M | 20.35M | 40.59M | 29.66M | 34.38M | 53.15M | 31.64M | 47.03M | -3.55M | 16.29M |
| Net Income Ratio | 0.81% | 1.03% | 1.22% | 0.95% | 0.25% | -0.23% | -2.75% | -1.20% | -0.61% | -1.51% | 0.59% | 1.20% | 0.89% | 1.31% | 2.06% | 1.25% | 2.07% | -0.21% | 1.07% |
| EPS | 0.57 | 0.66 | 0.64 | 0.43 | 0.10 | -0.08 | -1.49 | -0.82 | -0.48 | -1.18 | 0.56 | 1.14 | 0.73 | 0.95 | 1.47 | 0.81 | 1.19 | -0.09 | 0.66 |
| EPS Diluted | 0.57 | 0.66 | 0.64 | 0.43 | 0.10 | -0.08 | -1.44 | -0.82 | -0.48 | -1.18 | 0.56 | 1.13 | 0.70 | 0.92 | 1.45 | 0.81 | 1.19 | -0.09 | 0.66 |
| Weighted Avg Shares Out | 122.61M | 122.61M | 122.61M | 122.61M | 122.61M | 117.14M | 75.51M | 59.57M | 43.76M | 44.04M | 36.15M | 35.53M | 36.38M | 36.23M | 36.09M | 39.13M | 39.66M | 39.66M | 24.58M |
| Weighted Avg Shares Out (Dil) | 122.61M | 122.61M | 122.61M | 122.61M | 122.61M | 117.14M | 78.51M | 59.57M | 43.76M | 44.04M | 36.15M | 35.93M | 37.50M | 37.18M | 36.55M | 39.13M | 39.66M | 39.66M | 24.58M |
Source: https://incomestatements.info
Category: Stock Reports